4.8 Article

CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two loci

期刊

NATURE COMMUNICATIONS
卷 10, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-019-13403-y

关键词

-

资金

  1. City of Vienna
  2. Austrian Federal Ministry of Education, Science, and Research
  3. Austrian Forschungsfoerderungsgesellschaft (FFG) through the Bridge Early Phase program [846561]
  4. Ontario Institute for Cancer Research through Government of Ontario
  5. IMBA
  6. Austrian Academy of Sciences (OEAW)
  7. Eucodis Bioscience

向作者/读者索取更多资源

CRISPR-Cas9 is an efficient and versatile tool for genome engineering in many species. However, inducible CRISPR-Cas9 editing systems that regulate Cas9 activity or sgRNA expression often suffer from significant limitations, including reduced editing capacity, off-target effects, or leaky expression. Here, we develop a precisely controlled sgRNA expression cassette that can be combined with widely-used Cre systems, termed CRISPR-Switch (SgRNA With Induction/Termination by Cre Homologous recombination). Switch-ON facilitates controlled, rapid induction of sgRNA activity. In turn, Switch-OFF-mediated termination of editing improves generation of heterozygous genotypes and can limit off-target effects. Furthermore, we design sequential CRISPR-Switch-based editing of two loci in a strictly programmable manner and determined the order of mutagenic events that leads to development of glioblastoma in mice. Thus, CRISPR-Switch substantially increases the versatility of gene editing through precise and rapid switching ON or OFF sgRNA activity, as well as switching OVER to secondary sgRNAs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Base editor scanning charts the DNMT3A activity landscape

Nicholas Z. Lue, Emma M. Garcia, Kevin C. Ngan, Ceejay Lee, John G. Doench, Brian B. Liau

Summary: In this study, we use base editing and a DNA methylation reporter to scan mutations of DNMT3A in situ in cells. We identify mutations throughout the protein that disrupt function, including mutations at the interdomain interface that block allosteric activation. Surprisingly, we also find mutations in the PWWP domain that modulate enzyme activity by affecting DNA affinity.

NATURE CHEMICAL BIOLOGY (2023)

Article Multidisciplinary Sciences

Accounting for small variations in the tracrRNA sequence improves sgRNA activity predictions for CRISPR screening

Peter C. DeWeirdt, Abby V. McGee, Fengyi Zheng, Ifunanya Nwolah, Mudra Hegde, John G. Doench

Summary: This study develops a new on-target model that provides optimal predictions for multiple tracrRNA variants and demonstrates significant improvement over previous prediction models on a new dataset. By analyzing the differences in sgRNA activity between tracrRNA variants, the authors identify Pol III transcription termination as a strong determinant of sgRNA activity. These findings are expected to enhance the performance of CRISPR screening and inform future research on tracrRNA engineering and sgRNA modeling.

NATURE COMMUNICATIONS (2022)

Article Oncology

Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer

Kimberly R. Hagel, Rand Arafeh, Sydney Gang, Taylor E. Arnoff, Rebecca C. Larson, John G. Doench, Nathan D. Mathewson, Kai W. Wucherpfennig, Marcela Maus, William C. Hahn

Summary: This study uncovers multiple antigen-dependent and independent mechanisms of CAR T-cell evasion by pancreatic cancer, including the loss of genes involved in GPI-anchor biosynthesis and attachment pathway and genes that regulate tumor transcriptional responses. The identification of these resistance mechanisms provides insights into the landscape of tumor cell intrinsic resistance and potential approaches to improve CAR T-cell therapy efficacy in pancreatic cancer.

CANCER RESEARCH (2023)

Article Multidisciplinary Sciences

ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling

Matteo Gentili, Bingxu Liu, Malvina Papanastasiou, Deborah Dele-Oni, Marc A. Schwartz, Rebecca J. Carlson, Aziz M. Al'Khafaji, Karsten Krug, Adam Brown, John G. Doench, Steven A. Carr, Nir Hacohen

Summary: In this study, genes regulating STING trafficking were systematically characterized, and their impact on STING-mediated responses was examined. The study revealed that the ESCRT complex promotes STING degradation and terminates STING signaling. Furthermore, a UBAP1 mutation was found to increase steady-state STING-dependent responses. Overall, this study uncovers the role of the ESCRT complex in regulating STING signaling.

NATURE COMMUNICATIONS (2023)

Article Oncology

The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma

Yue Yan, Marc-Andre Gauthier, Ahmad Malik, Iosifina Fotiadou, Michael Ostrovski, Dzana Dervovic, Logine Ghadban, Ricky Tsai, Gerald Gish, Sampath Kumar Loganathan, Daniel Schramek

Summary: The aim of this study is to understand the signaling mechanisms of RIPK4 in SCCs. Through gene profiling and targeted CRISPR screening, we identified ELOVL4 as a downstream target of RIPK4. Our data from in vitro and in vivo mouse experiments show that the NOTCH-RIPK4-IRF6-ELOVL4 signaling axis functions as a potent tumor suppressor in SCCs.

CANCERS (2023)

Correction Genetics & Heredity

The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression (vol 43, pg 212, 2011)

Daniel Schramek, Athanassios Kotsinas, Arabella Meixner, Teiji Wada, Ulrich Elling, J. Andrew Pospisilik, G. Gregory Neely, Ralf-Harun Zwick, Verena Sigl, Guido Forni, Manuel Serrano, Vassilis G. Gorgoulis, Josef M. Penninger

NATURE GENETICS (2023)

Article Oncology

(R)-2-Hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-Mutant Cancers br

Kathryn Gunn, Matti Myllykoski, John Z. Cao, Manna Ahmed, Bofu Huang, Betty Rouaisnel, Bill H. Diplass, Michael M. Levitt, Ryan Looper, John G. Doench, Keith L. Ligon, Harley I. Kornblum, Samuel K. McBrayers, Hai Yan, Cihangir Duy, Lucy A. Godley, Peppi Koivunen, Julie-Aurore Losman

Summary: Oncogenic mutations in IDH1 and IDH2 are commonly found in various cancers, including AML and glioma. The mutant IDH enzymes produce (R)-2HG, which is believed to promote cellular transformation by disrupting 2OG-dependent enzymes. This study reveals that (R)-2HG inhibits KDM5 histone lysine demethylases, contributing to cellular transformation in IDH-mutant AML and glioma.

CANCER DISCOVERY (2023)

Article Oncology

Addressing TumorHeterogeneity by Sensitizing Resistant Cancer Cells to T cell-Secreted Cytokines

Yoshinaga Ito, Deng Pan, Wubing Zhang, Xixi Zhang, Tiffany Y. Juan, Jason W. Pyrdol, Oleksandr Kyrysyuk, John G. Doench, X. Shirley Liu, Kai W. Wucherpfennig

Summary: Tumor heterogeneity is a major obstacle in cancer therapy, including immunotherapy. By targeting autophagy and TNF signaling pathways, MHC-I-deficient tumor cells can be sensitized to T cell-mediated apoptosis. Antigens from apoptotic MHC-I-deficient tumor cells can be efficiently cross-presented by dendritic cells, leading to increased infiltration of T cells producing IFN-γ and TNF-α. Targeting both pathways enables T cell-mediated elimination of tumors with a substantial population of resistant, MHC-I-deficient cells.

CANCER DISCOVERY (2023)

Article Medicine, Research & Experimental

Developing SHP2-based combination therapy for KRAS-amplified cancer

Tianxia Li, Osamu Kikuchi, Jin Zhou, Yichen Wang, Babita Pokharel, Klavdija Bastl, Prafulla Gokhale, Aine Knott, Yanxi Zhang, John G. Doench, Zandra V. Ho, Daniel V. T. Catenacci, Adam J. Bass

Summary: Gastroesophageal adenocarcinomas (GEAs) frequently exhibit amplification of KRAS gene, resulting in overexpression of WT KRAS protein. This study investigates potential targets to enhance the efficacy of SHP2 inhibition in KRAS-amplified GEA, including those within the MAPK pathway and upstream RTKs. In vitro and in vivo experiments demonstrate that pan-ERBB kinase inhibition has potent cytotoxicity. Additionally, the combination of CDK4/6 inhibition with SHP2 inhibition shows greater efficacy in KRAS-amplified GEA compared to KRAS-mutant tumors. These findings suggest potential therapeutic combinations for clinical study in KRAS-amplified GEAs.

JCI INSIGHT (2023)

Article Oncology

In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target

Ana Vujovic, Laura de Rooij, Ava Keyvani Chahi, He Tian Chen, Brian A. Yee, Sampath K. Loganathan, Lina Liu, Derek C. H. Chan, Amanda Tajik, Emily Tsao, Steven Moreira, Pratik Joshi, Joshua Xu, Nicholas Wong, Zaldy Balde, Soheil Jahangiri, Sasan Zandi, Stefan Aigner, John E. Dick, Mark D. Minden, Daniel Schramek, Gene W. Yeo, Kristin J. Hope

Summary: Acute myeloid leukemia (AML) is driven by leukemic stem cells (LSC) and identifying the determinants of LSCs is challenging. This study identified a group of RNA-binding proteins (RBPs) enriched in human AML LSCs. Through a stem cell-adapted CRISPR screen, they found 32 essential RBPs for LSCs and discovered that ELAVL1, an RBP, plays a crucial role in AML propagation by regulating mitochondrial metabolism. These findings highlight the importance of RBPs as therapeutic targets in AML.

BLOOD CANCER DISCOVERY (2023)

Article Multidisciplinary Sciences

Ascl1 and Ngn2 convert mouse embryonic stem cells to neurons via functionally distinct paths

Gintautas Vainorius, Maria Novatchkova, Georg Michlits, Juliane Christina Baar, Cecilia Raupach, Joonsun Lee, Ramesh Yelagandula, Marius Wernig, Ulrich Elling

Summary: In this study, the authors show that cells can take two mechanistically distinct paths in the same transition paradigm when driven by the similar proneural factors Ascl1 and Ngn2. Ascl1 dismantles the pluripotency network and installs neuronal and trophoblast cell fates, while Ngn2 generates a neural stem cell-like intermediate supported by incomplete shutdown of the pluripotency network.

NATURE COMMUNICATIONS (2023)

Review Immunology

CRISPR screens for functional interrogation of immunity

Hao Shi, John G. Doench, Hongbo Chi

Summary: CRISPR-based technologies offer a powerful platform for unbiased screening and functional genomics in various fields, including immunology. These technologies have uncovered previously unknown intracellular drivers and intercellular regulators in immune cells, and have expanded the readouts to the transcriptome for better mechanistic insights. CRISPR screens also allow for mapping of genetic interactions to identify genes that synergize or alleviate complex immune phenotypes.

NATURE REVIEWS IMMUNOLOGY (2023)

Meeting Abstract Ophthalmology

Dissection of the SDC1-GPR87 Coreceptor-Receptor Complex that Captures Tear Lacritin for Promotion and Restoration of Ocular Surface Homeostasis

Karina Luiza Dias Teixeira, Mazhar Adli, John Doench, Gordon W. Laurie

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2022)

Meeting Abstract Oncology

ELUCIDATING THE ROLE OF LONG NON-CODING RNAS IN PEDIATRIC HIGH GRADE GLIOMAS

Jessica W. Tsai, Frank P. B. Dubois, Dayle K. Wang, Alexander Crane, Alexandra L. Condurat, Brian Krug, Adam Brown, John G. Doench, Nada Jabado, Pratiti Bandopadhayay

NEURO-ONCOLOGY (2022)

暂无数据